Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Lung cancer is a leading cause of cancer death globally, with low survival rates attributed to late diagnosis and ineffective treatments.
• Novel biomarkers are crucial for improving outcomes in patients with advanced lung cancer.
• MicroRNAs (miRNAs) are key gene regulators with potential as diagnostic, prognostic, and predictive biomarkers in cancer.

Purpose of the Study:

• To identify deregulated microRNAs (miRNAs) in lung cancer tissues compared to normal tissues.
• To investigate the role of miRNA target genes in lung adenocarcinoma and lung squamous cell carcinoma.
• To assess the prognostic value of specific miRNAs in non-small cell lung cancer patient survival.

Main Methods:

• Global miRNA expression profiling using TaqMan arrays on paired tumor and normal lung tissues (n=38).
• Validation of miRNA target genes using The Cancer Genome Atlas (TCGA) lung adenocarcinoma (n=561) and lung squamous cell carcinoma (n=523) RNA-Seq datasets.
• Statistical analysis to identify significantly deregulated miRNAs (FC ≥ 2.0, p < 0.05) and assess associations with patient survival.

Main Results:

• Identified 33 significantly deregulated miRNAs in lung tumors versus normal tissues, irrespective of histology.
• Enrichment analysis revealed that genes targeted by these miRNAs are aberrantly expressed and modulate known lung cancer pathways.
• High expression of miR-25-3p was significantly associated with poorer patient survival in both lung adenocarcinoma and lung squamous cell carcinoma.

Conclusions:

• miR-25-3p shows potential as a prognostic biomarker for non-small cell lung cancer.
• Target genes of the identified miRNAs are involved in critical cancer pathways, including EGFR and TGFβ signaling.
• Further research into miRNA-based biomarkers could improve lung cancer diagnosis and treatment strategies.